| HOME >> BIOLOGY >> TECHNOLOGY |
OAKLAND, Calif., May 27 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT, TSX: WHT) -- World Heart Corporation (the "Company") today announced that on May 20, 2008, it had received a letter from the NASDAQ Hearings Panel stating that they had received the Company's request to appeal the NASDAQ Listing Qualification Staff determination to delist World Heart Corporation's securities from the NASDAQ Stock Market. Accordingly, the delisting action referenced in the NASDAQ Staff's determination letter has been stayed, pending a final written decision by the NASDAQ Hearings Panel.
This letter provided formal notice that the panel will consider our appeal at an oral/written hearing. The hearing will be held on Thursday, July 10, 2008, at 2:30 PM in Washington, DC.
This decision by the NASDAQ Hearings Panel means that the stock will continue to trade at least until the determination is made at this hearing.
About World Heart Corporation
WorldHeart is a developer of mechanical circulatory support systems. The Company is headquartered in Oakland, California, USA with additional facilities in Salt Lake City, Utah and Herkenbosch, Netherlands. WorldHeart's registered office is Ottawa, Ontario, Canada.
Any forward-looking statements in this release are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995 and include any statements regarding the Company's ability to regain
compliance with the NASDAQ Capital Market listing requirements, as well as
other statements that can be identified by the use of forward-looking
language, such as "believes," "feels," "expects," "may," "will," "should,"
"seeks," "plans," "anticipates," or "intends" or the negative of those
terms, or by discussions of strategy or intentions. Investors are cautioned
that all forward-looking statements involve risk and uncertainties,
including without limitation: the Company's immediate need for additional
capital, risks in product dev
'/>"/>
| SOURCE World Heart Corporation Copyright©2008 PR Newswire. All rights reserved |